Rapid Regression of Chemotherapy Refractory Lymphocyte Predominant Hodgkin's Disease after Administration of Rituximab (anti CD 20 Monoclonal Antibody) and Interleukin-2
- 1 January 1999
- journal article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 35 (5-6), 641-642
- https://doi.org/10.1080/10428199909169633
Abstract
No abstract availableKeywords
This publication has 1 reference indexed in Scilit: